Clinical Research

Tears Yield Possible MS Biomarker

The tears of MS patients contain high levels of an inflammation-inhibiting protein that might serve as a diagnostic biomarker for MS

MS presents with a wide variety of symptoms, making accurate diagnosis difficult and requiring...

Clinical Research

MS Research Roundup: February 12, 2014

Mystery Myelin Drug to Be Tested; Mapping MS Depression in Women; Drug Marketing Investigation; Shirley Temple Black, MS Advocate

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, People

MS Patient, Ph.D.: Is 23andMe Doing It Right?

I was conflicted about whether direct-to-consumer DNA analysis services were a good idea, a stance I seemingly share with the FDA

As an MS patient, the last few years have been very exciting on the genetic frontier of...

Clinical Research

3-Year Average Delay in Identifying SPMS Transition

Diagnostic uncertainty regarding the transition from RRMS to SPMS may last about 3 years, with the delay potentially affecting not only patient care but also research

Diagnostic uncertainty regarding the transition from relapsing-remitting multiple sclerosis to secondary progressive MS may last about...

Clinical Research

Exploiting the EBV-MS Link to Quell Secondary Progressive Disease

Adoptive immunotherapy targeting EBV-infected B cells was safe and improved symptoms in a case study of secondary progressive MS

Adoptive immunotherapy that targets the immune system response to EBV-infected B cells helped...

Clinical Research

MS Research Roundup: February 7, 2014

Latest Myelin-Repair Candidate; Crowdsourcing Clinical Trials; Fingolimod Pregnancy Caution; Japan Neuroimmunology Meeting News

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, Meetings, Methods

MS Research Roundup: February 5, 2014

Clinical Trial Data Open to Scientists; Innate Immunity in Progressive MS; Paying for MS Drugs

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, Laboratory Research

MS Patient, Ph.D.: MS and Vitamin D: What’s a Patient to Do?

In the face of suggestive but inconclusive studies, Emily Willingham explains why she chooses to take 5,000 IU of vitamin D daily and vows to stop declining her mother’s offer of cod liver oil

The answer is easy for me: When I first started having symptoms, no one tested my...

Clinical Research, People

Teriflunomide Gets High Marks in Yet Another Phase 3 Trial

This placebo-controlled phase 3 study of oral teriflunomide for patients with relapsing MS concluded, as have previous studies, that the disease-modifying agent is safe and efficacious

Evidence continues to accumulate that the disease-modifying agent teriflunomide may be a good option for...

Clinical Research

MS Research Roundup: January 31, 2014

New Molecule for Myelin Repair in Mice; Synapses Under Fire; New Dose for Copaxone; Mind-Altering Microbes

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, Laboratory Research

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Tears Yield Possible MS Biomarker

MS Research Roundup: February 12, 2014

MS Patient, Ph.D.: Is 23andMe Doing It Right?

3-Year Average Delay in Identifying SPMS Transition

Exploiting the EBV-MS Link to Quell Secondary Progressive Disease

MS Research Roundup: February 7, 2014

MS Research Roundup: February 5, 2014

MS Patient, Ph.D.: MS and Vitamin D: What’s a Patient to Do?

Teriflunomide Gets High Marks in Yet Another Phase 3 Trial

MS Research Roundup: January 31, 2014

Pages

MSDF Footer

Search form

Clinical Research

Pages